Low-dose intermittent alemtuzumab in the treatment of Sezary syndrome: clinical and immunologic findings in 14 patientsMaria Grazia Bernengo, M. T. Fierro, F Lisa et al.|Haematologica|2007Cited by 175
Regulatory T cells in the skin lesions and blood of patients with systemic sclerosis and morphoeaEmiliano Antiga, Marzia Caproni, Angelo Valerio Marzano et al.|British Journal of Dermatology|2010Cited by 142